Jade Biosciences (JBIO) Minority Interest (2020 - 2021)

Jade Biosciences (JBIO) posted Minority Interest of $4.0 million for Q2 2021, little changed on a QoQ basis from $4.0 million in Q4 2020.

Jade Biosciences (JBIO) Minority Interest (2020 - 2021) Analysis & Trends

Jade Biosciences' Minority Interest history runs 2 years deep, the most recent figure standing at $4.0 million for Q2 2021.

  • Quarterly Minority Interest changed N/A year-over-year to $4.0 million in Q2 2021, while the trailing twelve-month figure through Jun 2021 was $4.0 million (changed N/A YoY) and the FY2020 annual result came in at $4.0 million, changed N/A from the prior year.
  • Minority Interest was $4.0 million for Q2 2021 at Jade Biosciences, roughly flat from $4.0 million in the prior quarter.
  • Across five years, Minority Interest topped out at $4.0 million in Q4 2020 and bottomed at $4.0 million in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Jade Biosciences 16.25 Mn 16.25 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2021 4.00 Mn
Dec 31, 2020 4.00 Mn